“Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S8. doi:10.25251/skin.2.supp.8.